2000
DOI: 10.1054/drup.2000.0150
|View full text |Cite
|
Sign up to set email alerts
|

Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
9
0

Year Published

2003
2003
2012
2012

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 74 publications
4
9
0
Order By: Relevance
“…Its significance was less important than serum Se (Lin et al, 2009). In this experiment the level of serum Cu was increased in bladder carcinoma which agreed with the previous studies (Huang et al, 1999;Hronek et al, 2000;McMillan et al, 2000;Mross, 2000;Valko et al, 2006). In many cancers, for example hepatoma and breast cancer, serum Cu/Zn also rises, which was same as that in this study (Marco et al, 2001;Zhai et al, 2003).…”
Section: Discussionsupporting
confidence: 92%
“…Its significance was less important than serum Se (Lin et al, 2009). In this experiment the level of serum Cu was increased in bladder carcinoma which agreed with the previous studies (Huang et al, 1999;Hronek et al, 2000;McMillan et al, 2000;Mross, 2000;Valko et al, 2006). In many cancers, for example hepatoma and breast cancer, serum Cu/Zn also rises, which was same as that in this study (Marco et al, 2001;Zhai et al, 2003).…”
Section: Discussionsupporting
confidence: 92%
“…Our finding is in agreement with most of the earlier studies suggesting that in the oesophageal cancer groups serum copper is higher [9][10][11]. Also, copper chelation by chelating agents has antiproliferative effects in many studies [12]. Brewer et al tested a drug known as tetrathiomolybdate, which binds up dietary copper in patients with different kinds of cancer.…”
Section: Discussionsupporting
confidence: 92%
“…This metronomic dosing has been demonstrated to exhibit antitumor and anti-angiogenic effects. [23][24][25]37,39 However, in our model, treatment with continuous infusion 5-FU alone did not reduce tumor angiogenesis, and its addition to ATN-161 did not further decrease vessel density in the combination-therapy group either. However, the finding that metronomic therapy did not work in our model is not unique and has been reported by others.…”
Section: Discussionmentioning
confidence: 85%